143112-51-0,
(R)-(-)-NBD-APy,
(R)-(-)-1-(7-Nitro-4-benzofurazanyl)-3-pyrrolidinamine,
(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole,
3-Pyrrolidinamine,1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (3R)-,
(R)-(-)-4-(3-Aminopyrrolidino)-7-nitrobenzofurazan,
SCHEMBL3034016,
CTK4C3486,
(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)benzofurazan,
DTXSID10576807,
ZINC6505630,
MFCD00191510,
AKOS030530709,
(r)-4-nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole,
(3R)-1-(7-Nitro-2,1,3-benzoxadiazol-4-yl)pyrrolidin-3-amine,
(3R)-1-(4-Nitro-2,1,3-benzoxadiazole-7-yl)-3alpha-pyrrolidinamine,
(R)-(-)-NBD-APY [=(R)-(-)-4-NITRO-7-(3-AMINOPYRROLIDIN-1-YL)-2,1,3-BENZOXADIAZOLE],
(R)-(-)-NBD-APy [=(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination],
A5563,
(R)-1-(7-Nitrobenzo[c][1,2,5]oxadiazol-4-yl)pyrrolidin-3-amine,